Credit Industriel ET Commercial Buys Shares of 121,258 STAAR Surgical Company $STAA

Credit Industriel ET Commercial purchased a new position in shares of STAAR Surgical Company (NASDAQ:STAA) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 121,258 shares of the medical instruments supplier’s stock, valued at approximately $3,258,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of STAAR Surgical by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,390 shares of the medical instruments supplier’s stock valued at $518,000 after purchasing an additional 1,267 shares during the period. Goldman Sachs Group Inc. lifted its stake in STAAR Surgical by 33.4% in the first quarter. Goldman Sachs Group Inc. now owns 544,843 shares of the medical instruments supplier’s stock valued at $9,606,000 after buying an additional 136,390 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of STAAR Surgical by 11.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 123,347 shares of the medical instruments supplier’s stock valued at $2,175,000 after buying an additional 12,841 shares during the period. CWM LLC boosted its holdings in shares of STAAR Surgical by 74.1% in the second quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 665 shares during the period. Finally, AlphaQuest LLC increased its position in shares of STAAR Surgical by 197.4% during the second quarter. AlphaQuest LLC now owns 10,879 shares of the medical instruments supplier’s stock worth $183,000 after acquiring an additional 7,221 shares in the last quarter. Institutional investors and hedge funds own 96.70% of the company’s stock.

Insider Transactions at STAAR Surgical

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. bought 27,485 shares of STAAR Surgical stock in a transaction dated Friday, January 9th. The stock was bought at an average cost of $22.05 per share, for a total transaction of $606,044.25. Following the purchase, the insider owned 15,453,629 shares of the company’s stock, valued at $340,752,519.45. The trade was a 0.18% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased a total of 1,934,138 shares of company stock valued at $50,485,791 in the last 90 days. 0.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on STAA shares. Canaccord Genuity Group reduced their target price on shares of STAAR Surgical from $30.75 to $22.00 and set a “hold” rating for the company in a research note on Thursday, January 15th. Wells Fargo & Company boosted their price target on STAAR Surgical from $28.00 to $30.75 and gave the company an “equal weight” rating in a report on Wednesday, December 10th. Weiss Ratings reiterated a “sell (d)” rating on shares of STAAR Surgical in a report on Thursday, January 22nd. Stifel Nicolaus cut their target price on STAAR Surgical from $28.00 to $19.00 and set a “hold” rating on the stock in a research note on Monday, February 9th. Finally, BTIG Research reaffirmed a “neutral” rating on shares of STAAR Surgical in a research report on Tuesday, January 6th. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $20.91.

STAAR Surgical Price Performance

Shares of STAA opened at $16.10 on Monday. The company has a market cap of $800.81 million, a PE ratio of -8.26 and a beta of 1.06. The firm has a 50-day moving average of $21.40 and a 200-day moving average of $24.76. STAAR Surgical Company has a one year low of $14.69 and a one year high of $30.81.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.